Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophrenia

dc.creatorSoares, Bruno Lobão
dc.creatorOliveira, João Paulo Maia de
dc.creatorMachado-de-Sousa, João Paulo
dc.creatorBaker, Glen B.
dc.creatorDursun, Serdar
dc.creatorHallak, Jaime E. C.
dc.date.accessioned2018-06-16T15:43:29Z
dc.date.accessioned2022-10-06T12:57:04Z
dc.date.available2018-06-16T15:43:29Z
dc.date.available2022-10-06T12:57:04Z
dc.date.created2018-06-16T15:43:29Z
dc.date.issued2011-09
dc.identifierSOARES, Bruno Lobão et al.Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophrenia. Revista Brasileira de Psiquiatria, v. 33, p. 223-224, 2011. Disponível em: <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462011000300003&lng=en&tlng=en>. Acesso em: 23 mar. 2018.
dc.identifier1809-452X
dc.identifierhttps://repositorio.ufrn.br/jspui/handle/123456789/25437
dc.identifierhttp://dx.doi.org/10.1590/S1516-44462011000300003
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3961603
dc.publisherAssociação Brasileira de Psiquiatria
dc.rightsAcesso Aberto
dc.subjectSchizophrenia
dc.titleTargeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophrenia
dc.typearticle


Este ítem pertenece a la siguiente institución